[ad_1]
Barclays raised shares of CytomX Therapeutics to a “strong-buy” rating in a report on Tuesday.
[ad_2]
Source link
Related Posts
AerSale Corporation (NASDAQ:ASLE) Director Judith Ann Fedder Buys 2,100 Shares
[ad_1] AerSale Corporation (NASDAQ:ASLE – Get Free Report) Director Judith Ann Fedder purchased 2,100 shares of the stock in a…
Cresset Asset Management LLC Sells 4,228 Shares of Fortinet, Inc. $FTNT
[ad_1] Cresset Asset Management LLC trimmed its stake in Fortinet, Inc. (NASDAQ:FTNT – Free Report) by 17.1% during the 1st…
Computer Modelling Group (TSE:CMG) Shares Down 18.3% – Here's Why
[ad_1] Computer Modelling Group (TSE:CMG) Stock Price Down 18.3% – Here’s Why [ad_2] Source link